Absci

ABSCI CORP

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Stock,Market,Graph,Trading,Analysis,Investment,Financial,,Stock,Exchange,Financial

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ABSI

ALLT

ALUR

ASNS

AXDX

DBVT

DEVS

FNGR

GRAL

LRHC

LUCY

PLRZ

UBER

WBUY

XHLD

XTKG

Las acciones de Everus Construction Group suben un 14,7 % tras superar expectativas de ganancias y ventas en el primer trimestre.

Acciones de Everus Construction (ECG) se disparan un 15%; Aquí están 20 acciones que se mueven en premercado

ACCD

ARKG

ARKK

ARKQ

ARKX

ESLT

ILMN

NTLA

OKLO

PATH

Descubre las recientes decisiones de Ark Invest en energía, defensa y genética, con transacciones millonarias en empresas clave.

Ark Invest adquiere y vende acciones clave en energía, defensa y tecnología genética

Equities

General

INTC

NVDA

Absci Corporation y AMD se unen para transformar el descubrimiento de medicamentos mediante inteligencia artificial avanzada.

Absci y AMD se asocian para revolucionar el descubrimiento de medicamentos con IA

Absci Corp

Management

Press Releases

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

IPOs

Absci Announces Proposed Public Offering of Common Stock

Absci Announces Pricing of Public Offering of Common Stock

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Earnings

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Absci to Participate in Upcoming Investor Conferences

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

ATEC

IRTC

ORCL

ADC Therapeutics

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

CytomX Therapeutics

Emergent BioSolutions

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Gossamer Bio

I-MAB

Inventiva S.A. - American Depository Shares

Inventiva

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Kodiak Sciences

Keros Therapeutics

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

MeiraGTx Hldgs

Monopar Therapeutics

Ocugen

Organogenesis Holdings

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Regenxbio

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Savara

Verastem

Morgan Stanley

Needham

Keybanc

Guggenheim

HC Wainwright & Co.

Comments

Absci

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL